The ROE (Return on Equity) of Allogene Therapeutics Inc (ALLO) is -61.01%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -61.01% |
| 2023-12-31 | -63.89% |
| 2022-12-31 | -49.95% |
| 2021-12-31 | -28.05% |
| 2020-12-31 | -23.18% |
| 2019-12-31 | -29.35% |
| 2018-12-31 | -30.08% |